Prevalence of Nonalcoholic Steatohepatitis and Associated Fibrosis Stages Among US Adults Using Imaging-Based vs Biomarker-Based Noninvasive Tests
# Introduction Nonalcoholic fatty liver disease (NAFLD) is believed to be the most common chronic liver disease worldwide. Therapies are under development for nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD, such that the prevalence of NASH with liver fibrosis, which is likely to...
Saved in:
| Main Authors: | Jesse Fishman, Tom O'Connell, Christina M. Parrinello, Jonathan J. Woolley, Eric Bercaw, Michael R. Charlton |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2024-02-01
|
| Series: | Journal of Health Economics and Outcomes Research |
| Online Access: | https://doi.org/10.36469/001c.92223 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy
by: Kanae Hirose, et al.
Published: (2016-01-01) -
Nonalcoholic Steatohepatitis: An Evolving Diagnosis
by: Brent A Neuschwander-Tetri
Published: (2000-01-01) -
Nonalcoholic Steatohepatitis in a Patient with Ataxia-Telangiectasia
by: Trinidad Caballero, et al.
Published: (2014-01-01) -
Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
by: Mehmet Yalniz, et al.
Published: (2006-01-01) -
Network pharmacology-based investigation of the pharmacological mechanisms of diosgenin in nonalcoholic steatohepatitis
by: Peiyuan Gu, et al.
Published: (2025-03-01)